| SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and-independent mechanisms S Osataphan, C Macchi, G Singhal, J Chimene-Weiss, V Sales, C Kozuka, ... JCI insight 4 (5), 2019 | 201 | 2019 |
| Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ... Cancer discovery 7 (9), 973-983, 2017 | 124 | 2017 |
| Bromodomain inhibition reveals FGF15/19 as a target of epigenetic regulation and metabolic control C Kozuka, V Efthymiou, VM Sales, L Zhou, S Osataphan, Y Yuchi, ... Diabetes 71 (5), 1023-1033, 2022 | 6 | 2022 |
| 1557-P: Ctcfl Is a Fasting-Induced Epigenetic Regulator of Lipid Metabolism and Ketogenesis in the Liver V EFTHYMIOU, L POULOS, L STRAUB, V NAVARRETE, B OZTURK, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 280-OR: CTCFL Is a Fasting-Induced Epigenetic Regulator That Modulates Lipid and Cholesterol Metabolism in the Liver V Efthymiou, JI Chimene-Weiss, L Zhou, S Osataphan, L Su, ME Patti Diabetes 70 (Supplement_1), 2021 | | 2021 |
| Paternal Obesity and SGLT2 Inhibition Alter Expression of Placental Regulatory Genes L Su, S Osataphan, J Desmond, R Fang, J Chimene-Weiss, L Zhou, ... Journal of the Endocrine Society 5 (Supplement_1), A752-A753, 2021 | | 2021 |
| 373-OR: Paternal SGLT2 Inhibition Upregulates Hepatic Expression of Oxidative Phosphorylation Genes in Both Fetal and Adult Offspring L Su, S Osataphan, C Macchi, JI Chimene-Weiss, J Dreyfuss, H Pan, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 1847-P: SGLT2 Inhibition Reduces Paternal Intergenerational Transmission of Metabolic Disease in Mice with Dietary Obesity S OSATAPHAN, J CHIMENE-WEISS, C MACCHI, LEI SU, N LORANGER, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| The SGLT2 Inhibitor Canagliflozin Induces Catabolic Transcriptional and Metabolic Switching and Increases FGF-21 in Mice with Dietary Obesity S Osataphan, C Macchi, V Sales, C Kozuka, JI Chimene-Weiss, ... Diabetes 67 (Supplement_1), 2018 | | 2018 |
| SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and-independent mechanisms. JCI Insight. 2019; 4 (5) S Osataphan, C Macchi, G Singhal, J Chimene-Weiss, V Sales, C Kozuka | | |
